S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
AMZN   1,777.43 (+0.57%)
GE   8.91 (+0.11%)
TSLA   259.75 (+0.72%)
ACB   3.59 (-4.52%)
NFLX   286.28 (+0.71%)
BAC   30.18 (+1.51%)
S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
AMZN   1,777.43 (+0.57%)
GE   8.91 (+0.11%)
TSLA   259.75 (+0.72%)
ACB   3.59 (-4.52%)
NFLX   286.28 (+0.71%)
BAC   30.18 (+1.51%)
Log in

Pharming Group Stock Price, News & Analysis (OTCMKTS:PHGUF)

$1.25
-0.10 (-7.41 %)
(As of 10/16/2019 04:00 PM ET)
Today's Range
$1.22
Now: $1.25
$1.25
50-Day Range
$1.22
MA: $1.35
$1.44
52-Week Range
$0.74
Now: $1.25
$1.45
Volume1,700 shs
Average Volume3,748 shs
Market Capitalization$723.78 million
P/E RatioN/A
Dividend YieldN/A
Beta1.22
Pharming Group N.V., a specialty pharmaceutical company, develops and produces human therapeutic proteins for the treatment of rare diseases and unmet medical needs. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of angioedema attacks in patients with acute hereditary angioedema (HAE) in Europe, the United States, Israel, European Union countries, Norway, Iceland, and Liechtenstein. Read More…

Industry, Sector and Symbol

Industry Tobacco products
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PHGUF
CUSIPN/A
CIKN/A
Phone31-71-524-7400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$101.24 million
Book Value$0.04 per share

Profitability

Miscellaneous

Employees183
Market Cap$723.78 million
Next Earnings DateN/A
OptionableNot Optionable

Receive PHGUF News and Ratings via Email

Sign-up to receive the latest news and ratings for PHGUF and its competitors with MarketBeat's FREE daily newsletter.


Pharming Group (OTCMKTS:PHGUF) Frequently Asked Questions

What is Pharming Group's stock symbol?

Pharming Group trades on the OTCMKTS under the ticker symbol "PHGUF."

How were Pharming Group's earnings last quarter?

Pharming Group (OTCMKTS:PHGUF) issued its quarterly earnings data on Thursday, March, 5th. The biotechnology company reported $0.05 EPS for the quarter, beating analysts' consensus estimates of $0.04 by $0.01. View Pharming Group's Earnings History.

Has Pharming Group been receiving favorable news coverage?

Media stories about PHGUF stock have trended positive recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Pharming Group earned a coverage optimism score of 2.1 on InfoTrie's scale. They also assigned news articles about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Pharming Group.

Who are some of Pharming Group's key competitors?

What other stocks do shareholders of Pharming Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pharming Group investors own include GALAPAGOS NV/S (GLPG), ArcelorMittal (MT), Net Element (NETE), Pieris Pharmaceuticals (PIRS), Bausch Health Companies (BHC), BIOLINERX LTD/S (BLRX), TIGENIX/S (TIG), Accsys Technologies (AXS), Powerflute Oyj (POWR) and Cellectis (CLLS).

Who are Pharming Group's key executives?

Pharming Group's management team includes the folowing people:
  • Dr. Sijmen de Vries M.D., MBA, Chairman of Management Board & CEO (Age 60)
  • Mr. Robin Wright BA (Oxon), FCA., CFO & Member of Management Board (Age 55)
  • Dr. Bruno M. L Giannetti, COO & Member of Management Board (Age 67)
  • Dr. Pericles Calias, Chief Scientific Officer (Age 51)
  • Ms. Anne-Marie de Groot, Sr. VP of Organisational Devel. (Age 38)

How do I buy shares of Pharming Group?

Shares of PHGUF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Pharming Group's stock price today?

One share of PHGUF stock can currently be purchased for approximately $1.25.

How big of a company is Pharming Group?

Pharming Group has a market capitalization of $723.78 million and generates $101.24 million in revenue each year. Pharming Group employs 183 workers across the globe.View Additional Information About Pharming Group.

What is Pharming Group's official website?

The official website for Pharming Group is http://www.pharming.com/.

How can I contact Pharming Group?

Pharming Group's mailing address is Darwinweg 24, Leiden P7, 2333 CR. The biotechnology company can be reached via phone at 31-71-524-7400 or via email at [email protected]


MarketBeat Community Rating for Pharming Group (OTCMKTS PHGUF)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  146 (Vote Outperform)
Underperform Votes:  179 (Vote Underperform)
Total Votes:  325
MarketBeat's community ratings are surveys of what our community members think about Pharming Group and other stocks. Vote "Outperform" if you believe PHGUF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PHGUF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Featured Article: What are gap-down stocks?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel